Search

Displaying results 8321 - 8330 of 10000 in total
  1. Drug

    Somavaratan

    go.drugbank.com/drugs/DB12421
    Investigational

    Somavaratan has been used in trials studying the treatment of Growth Disorders and Adult Growth Hormone Deficiency.

  2. Drug

    Verdiperstat

    go.drugbank.com/drugs/DB12440
    Investigational

    Verdiperstat has been used in trials studying the basic science and treatment of Multiple System Atrophy (MSA).

  3. Drug

    Tovetumab

    go.drugbank.com/drugs/DB12609
    Investigational

    Tovetumab has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Advanced Solid Malignancies.

  4. Drug

    BMS-188797

    go.drugbank.com/drugs/DB12619
    Investigational

    BMS-188797 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

  5. Drug

    Ibipinabant

    go.drugbank.com/drugs/DB12649
    Investigational

    Ibipinabant has been used in trials studying the treatment of Obesity and Obesity and Type 2 Diabetes.

  6. Drug

    Omipalisib

    go.drugbank.com/drugs/DB12703
    Investigational

    Omipalisib has been used in trials studying the treatment of CANCER, Solid Tumours, and Idiopathic Pulmonary Fibrosis.

  7. Drug

    Mitoguazone

    go.drugbank.com/drugs/DB12967
    Investigational

    Mitoguazone has been used in trials studying the treatment of Lymphoma, HIV Infections, and Lymphoma, Non-Hodgkin.

  8. Drug

    Prusogliptin

    go.drugbank.com/drugs/DB20606
    Investigational

    Prusogliptin is under investigation in clinical trial NCT07026968 (A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 Diabetes … The usage of the INN stem '-gliptin' in the name indicates that Prusogliptin is a dipeptidyl aminopeptidase-IV inhibitor.

  9. Drug

    Amsilarotene

    go.drugbank.com/drugs/DB21085
    Investigational

    Amsilarotene is under investigation in clinical trial NCT00687596 (Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy … The usage of the INN stem '-arotene' in the name indicates that Amsilarotene is a arotinoid derivative.

  10. Drug

    Guretolimod

    go.drugbank.com/drugs/DB21487
    Investigational

    Guretolimod is under investigation in clinical trial NCT03416335 (A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile). … The usage of the INN stem '-tolimod' in the name indicates that Guretolimod is a toll-like receptor (TLR) agonist.